
1. malar j. 2018 oct 30;17(1):399. doi: 10.1186/s12936-018-2544-6.

prospective comparative multi-centre study imported plasmodium ovale wallikeri
and plasmodium ovale curtisi infections.

rojo-marcos g(1), rubio-muñoz jm(2), angheben a(3), jaureguiberry s(4),
garcía-bujalance s(5), tomasoni lr(6), rodríguez-valero n(7), ruiz-giardín jm(8),
salas-coronas j(9), cuadros-gonzález j(10), garcía-rodríguez m(11), molina-romero
i(12), lópez-vélez r(13), gobbi f(3), calderón-moreno m(14), martin-echevarría
e(15), elía-lópez m(16), llovo-taboada j(17); tropnet plasmodium ovale
investigator group.

collaborators: lago-nuñez m, castelli f, jaquetti j, alonso c, camprubí d,
górgolas-hernández-mora m, cuevas-tascón g, pérez-ayala a, guzmán-garcíamonge mt,
ribell-bachs m, serre-delcor n, martín-martín y, ramírez-olivencia g,
cogollos-agruña r, merino-fernández fj, garcía-castro a, cantudo-muñoz p,
belhassen-garcía m, martín-rabadán p, rubio-cuevas p, trigo-esteban e,
arévalo-serrano j.

author information: 
(1)hospital universitario príncipe de asturias, ctra de meco s/n, 28805, alcalá
de henares, madrid, spain. grojo.hupa@salud.madrid.org.
(2)instituto de salud carlos iii, majadahonda, madrid, spain.
(3)ospedale sacro cuore - calabria, negrar, verona, italy.
(4)hôpital pitié-salpêtrière, assistance publique des hôpitaux de paris (aphp),
paris, france.
(5)hospital universitario la paz-carlos iii, madrid, spain.
(6)spedali civili hospital, university brescia, brescia, italy.
(7)hospital clinic, barcelona, spain.
(8)hospital universitario de fuenlabrada, madrid, spain.
(9)hospital del poniente-el ejido, almería, spain.
(10)hospital universitario príncipe de asturias, ctra de meco s/n, 28805, alcalá 
de henares, madrid, spain.
(11)hospital general universitario de valencia, valencia, spain.
(12)hospital vall d´hebron-drassanes, barcelona, spain.
(13)hospital universitario ramón cajal, madrid, spain.
(14)hospital universitario gregorio marañón, madrid, spain.
(15)hospital universitario de guadalajara, guadalajara, spain.
(16)complejo hospitalario de navarra, pamplona, navarra, spain.
(17)complejo hospitalario universitario de santiago de compostela, coruña,
spain.

background: previous retrospective studies suggest plasmodium ovale
wallikeri seems longer latency period produces deeper
thrombocytopaenia plasmodium ovale curtisi. prospective studies were
warranted better assess interspecies differences.
methods: patients imported p. ovale spp. infection diagnosed thick or
thin film, rapid diagnostic test (rdt) polymerase chain reaction (pcr) were
recruited march 2014 may 2017. confirmed dna isolation
and classified p. o. curtisi p. o. wallikeri using partial sequencing of
the ssrrna gene. epidemiological, analytical clinical differences were
analysed statistical methods.
results: total 79 samples (35 p. o. curtisi 44 p. o. wallikeri) were
correctly genotyped. males predominate wallikeri group (72.7%), whereas were
48.6% curtisi group. conversely, 74.3% curtisi group patients 
african ethnicity, whilst 52.3% caucasians infected p. o. wallikeri.
after performing multivariate analysis, thrombocytopaenic patients
(p = 0.022), lower number platelets (p = 0.015), higher inr value
(p = 0.041), shorter latency caucasians (p = 0.034) significantly
seen p. o. wallikeri. rdt sensitivity 26.1% p. o. curtisi 42.4% 
p. o. wallikeri. nearly 20% species diagnosed pcr. total
bilirubin 3 mg/dl found three wallikeri cases. two patients with
curtisi infection haemoglobin 7 g/dl, one also icterus. 
wallikeri patient suffered haemophagocytosis. chemoprophylaxis failed in
14.8% 35% curtisi wallikeri patients, respectively. treated
patients various anti-malarials included artesunate recovered.
diabetes mellitus described 5 patients (6.32%), 4 patients wallikeri
group 1 curtisi.
conclusions: imported p. o. wallikeri infection may frequent males and
caucasians. malaria caused p. o. wallikeri produces thrombocytopaenia, 
higher inr shorter latency caucasians suggests pathogenic
species. severe cases seen species. chemoprophylaxis seems less
effective p. ovale spp. infection p. falciparum, anti-malarial
drug effective initial treatment. diabetes mellitus could risk factor 
for p. ovale spp. infection.

doi: 10.1186/s12936-018-2544-6 
pmcid: pmc6208040
pmid: 30376868  [indexed medline]

